CLINICAL_TRIALS
trial_result
· 2019-08-13
Clinical Trial Update: Efficacy and Safety of AMG0001 in Subjects With Critical Limb Ischemia [Phase 3]
Summary
Phase 3 trial of AMG0001 in critical limb ischemia was terminated; results have been posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: AnGes USA, Inc. | Conditions: Critical Limb Ischemia | Phase 3 | Status: TERMINATED | Results posted: 2019-08-13